[2]Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel lymph node biopsy in patients with breast
cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre
cohort study. Lancet Oncol 2013;14:609-18
[3]Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after
neoadjuvant chemotherapy in patients with node-positive breast cancer :the ACOSOG Z1071
(Alliance) clinical trial. JAMA 2013;310:1455-61
4[]Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy
in biopsy-proven node-positive breast cancer : the SN FNAC study. J Clin Oncol
2015;33:258-66
[5]Cortazar P, Zhang L, Untch M, et al. Meta-analysis results from the Collaborative Trials in
neoadjuvant breast cancer (CTNeoBC). Cancer Res 2012;72(24 suppl):P1 14-P1 20)
[6] Jackson RB, Mylander C, Rosman M, et al. Normal axillary ultrasound excludes heavy
nodal disease burden in patients with breast cancer. Ann Surg Oncol 2015; 22:3289-95
[7]INCa. Recommandations professionnelles. Cancer du sein non metastatique. Questions
d’actualité. 2012 .
